Mini review

The effects of Transcranial Direct Current Stimulation on food craving and food intake in individuals affected by obesity and overweight: a mini review of the magnitude of the effects

  • Obesity represents one of the wellness diseases concurring to increase the incidence of diabetes, cardiovascular diseases, and cancer. One of the main perpetuating factors of obesity is food craving, which is characterized by an urgent desire to eat a large and various amount of food, regardless of calories requirement or satiety signals, and it might be addressed to the alteration of the dorsolateral prefrontal cortex (DLPFC) activity. Despite most of the gold-standard therapies focus on symptom treatment only, non-invasive brain stimulation techniques such as transcranial direct current stimulation (tDCS) could help treat overeating by modulating specific neural pathways. The current systematic review was conducted to identify whether convergent evidence supporting the usefulness of tDCS to deal with food craving are present in the literature. The review was conducted by searching articles published up to January 1st 2022 on MEDLINE, Scopus and PsycInfo databases. We included studies investigating the effects of tDCS on food craving in subjects affected by overweight and obesity. According to eligibility criteria, 5 articles were included. Results showed that tDCS targeting left DLPFC with unipolar montage induced ameliorating effects on food craving. Controversial results were shown for the other studies, that might be ascribable to the use of bipolar montage, and the choice of other target areas. Further investigations including expectancy effect control, larger sample sizes and follow-up are needed to support more robust conclusions. To conclude, tDCS combined with the use of psychoeducative intervention, diet and physical activity, might represents a potential to manage food craving in individuals with overweight and obesity.

    Citation: Graziella Orrù, Valentina Cesari, Eleonora Malloggi, Ciro Conversano, Danilo Menicucci, Alessandro Rotondo, Cristina Scarpazza, Laura Marchi, Angelo Gemignani. The effects of Transcranial Direct Current Stimulation on food craving and food intake in individuals affected by obesity and overweight: a mini review of the magnitude of the effects[J]. AIMS Neuroscience, 2022, 9(3): 358-372. doi: 10.3934/Neuroscience.2022020

    Related Papers:

    [1] Justyna Gerłowska, Krzysztof Dmitruk, Konrad Rejdak . Facial emotion mimicry in older adults with and without cognitive impairments due to Alzheimer's disease. AIMS Neuroscience, 2021, 8(2): 226-238. doi: 10.3934/Neuroscience.2021012
    [2] Monireh Asadi Ghaleni, Forouzan Fattahi Masrour, Narjes Saryar, Alexandra J. Bratty, Ebrahim Norouzi, Matheus Santos de Sousa Fernandes, Georgian Badicu . Effects of an intervention combining physical activity and components of Amygdala and Insula Retraining (AIR) on sleep and working memory among older male adults. AIMS Neuroscience, 2024, 11(4): 421-438. doi: 10.3934/Neuroscience.2024025
    [3] Sairam Ramesh, Arosh S. Perera Molligoda Arachchige . Depletion of dopamine in Parkinson's disease and relevant therapeutic options: A review of the literature. AIMS Neuroscience, 2023, 10(3): 200-231. doi: 10.3934/Neuroscience.2023017
    [4] Ubaid Ansari, Alexi Omid, Dawnica Nadora, Jimmy Wen, Arman Omid, Forshing Lui . Outcomes of dietary interventions in the prevention and progression of Parkinson's disease: A literature review. AIMS Neuroscience, 2024, 11(4): 520-532. doi: 10.3934/Neuroscience.2024032
    [5] Anmol Kumar, Ajay Kumar Gupta, Prashant Kumar Singh . Novel perspective of therapeutic modules to overcome motor and nonmotor symptoms in Parkinson's disease. AIMS Neuroscience, 2024, 11(3): 312-340. doi: 10.3934/Neuroscience.2024020
    [6] I. Banegas, I. Prieto, A.B. Segarra, M. de Gasparo, M. Ramírez-Sánchez . Study of the Neuropeptide Function in Parkinson’s Disease Using the 6-Hydroxydopamine Model of Experimental Hemiparkinsonism. AIMS Neuroscience, 2017, 4(4): 223-237. doi: 10.3934/Neuroscience.2017.4.223
    [7] Zohaer Muttalib, Dana Aboukhalil, Chisom Nwosu, Dave D. Manguerra, Jimmy Wen, Ubaid Ansari, Meraj Alam, Ihab Abed, Ethan Tabaie, Ahmed Salem, Forshing Lui . Gluten and its relationship with inflammation and Parkinson's Disease: A literature review. AIMS Neuroscience, 2025, 12(1): 44-57. doi: 10.3934/Neuroscience.2025004
    [8] Marco Calabrò, Carmela Rinaldi, Giuseppe Santoro, Concetta Crisafulli . The biological pathways of Alzheimer disease: a review. AIMS Neuroscience, 2021, 8(1): 86-132. doi: 10.3934/Neuroscience.2021005
    [9] Adeshina O. Adekeye, Adedamola A. Fafure, Ayoola E. Ogunsemowo, Linus A. Enye, Olusola S. Saka, Oluwatosin O. Ogedengbe . Naringin ameliorates motor dysfunction and exerts neuroprotective role against vanadium-induced neurotoxicity. AIMS Neuroscience, 2022, 9(4): 536-550. doi: 10.3934/Neuroscience.2022031
    [10] Amber Woodard, Brandon Barbery, Reid Wilkinson, Jonathan Strozyk, Mathew Milner, Patrick Doucette, Jarred Doran, Kendra Appleby, Henry Atwill, Wade E. Bell, James E. Turner . The role of neuronal nitric oxide and its pathways in the protection and recovery from neurotoxin-induced de novo hypokinetic motor behaviors in the embryonic zebrafish (Danio rerio). AIMS Neuroscience, 2019, 6(1): 25-42. doi: 10.3934/Neuroscience.2019.1.25
  • Obesity represents one of the wellness diseases concurring to increase the incidence of diabetes, cardiovascular diseases, and cancer. One of the main perpetuating factors of obesity is food craving, which is characterized by an urgent desire to eat a large and various amount of food, regardless of calories requirement or satiety signals, and it might be addressed to the alteration of the dorsolateral prefrontal cortex (DLPFC) activity. Despite most of the gold-standard therapies focus on symptom treatment only, non-invasive brain stimulation techniques such as transcranial direct current stimulation (tDCS) could help treat overeating by modulating specific neural pathways. The current systematic review was conducted to identify whether convergent evidence supporting the usefulness of tDCS to deal with food craving are present in the literature. The review was conducted by searching articles published up to January 1st 2022 on MEDLINE, Scopus and PsycInfo databases. We included studies investigating the effects of tDCS on food craving in subjects affected by overweight and obesity. According to eligibility criteria, 5 articles were included. Results showed that tDCS targeting left DLPFC with unipolar montage induced ameliorating effects on food craving. Controversial results were shown for the other studies, that might be ascribable to the use of bipolar montage, and the choice of other target areas. Further investigations including expectancy effect control, larger sample sizes and follow-up are needed to support more robust conclusions. To conclude, tDCS combined with the use of psychoeducative intervention, diet and physical activity, might represents a potential to manage food craving in individuals with overweight and obesity.


    Abbreviations

    atDCS:

    anodal transcranial direct current stimulation; 

    BMI:

    Body Mass Index; 

    ctDCS:

    cathodal transcranial direct current stimulation; 

    DLPFC:

    dorsolateral prefrontal cortex; 

    lDLPFC:

    left dorsolateral prefrontal cortex; 

    PRISMA:

    Preferred Reporting Items for Systematic Review; 

    RCTs:

    randomized controlled trials; 

    rDLPFC:

    right dorsolateral prefrontal cortex; 

    tDCS:

    transcranial direct current stimulation; 

    VAS:

    visual analogue scale

    Neurodegenerative diseases are likely to be a scourge for our society in the course of the next century. Parkinson disease (PD) is the second most common neurodegenerative disease after Alzheimer disease [1], and it is characterized by the gradual worsening of various motor and cognitive symptoms [2]. The latter are often subtle at the onset and can occur many years prior to a diagnosis in different brain regions, which makes the sympthomalogy of the disease inivitable. Due to the progression of the pathology, physical parameters will be infected, such as walking and balance, and is accompanied by cogntive deficits, which will negatively impact the patient's quality of life [3],[4]. Therefore, pharmacological treatments are aimed at alleviating symptoms and improving functional capacities. They are mainly focused on the dopaminergic deficit of the black substance (i.e., the main anatomical characteristic of the pathology) [5]. For this purpose, levodopa has remained the leading treatment used, especially in the early stages of the disease. However, long-term use may lead to an intolerance, thus requiring increased doses, and sometimes causes motor fluctuations called dyskinesies, thus increasing the risk of falling and affecting quality of life (QoL) [6].

    Exercise has long been postulated as a theraputique intervention that can modify the short- and long-term clinical courses of patients with PD [7],[8]. Conversely, people with PD display low levels of physical activity and a prolonged sedentary behavior [9], which may negatively impact the clinical course of the disease [10]. Consequently, identifying and developing specific procedures to increase PA levels in this population is critical. Because exercise is a multidimensional activity with combined effects on both the physical and mental wellbeing, it would be more reasonable to assess the impact of exercise by measuring QoL changes. Indeed, several researchers have shown that exercise plays an important role as a supplement to drug therapy in relieving suffering and improving the QoL [11]. QoL outcomes are useful for attaining evidence of meaningful benefit, thus enhancing the significance of variables of interest and allowing for more holistic decision-making [12]. The link between QoL and physical activity has been increasingly consolidated in the literature [13], including in PD, whereby many studies have assessed various non-pharmacological treatments, including physical rehabilitation programs [14], Tai Chi Quan [15], and aquatic physiotherapy [16], which demonstrated an improvement in a patient's QoL and well being with the use of specific instruments to assess the QoL in this population [17].

    In practice, research with people with PD has been on the rise in the last 10 years. While adapted physical programs based on boxing and resistance exercices are emerging, few studies have documented its effectiveness. Furthermore, many of the studies conducted with people with PD did not necessarily take medication changes and the severity of the disease into account. Eventually, few interventions have been carried out over a period of more than a year, while PD progresses slowly. In light of these findings, the overall objective in the present study is to assess the long-term effects of adapted physical training (12 to 16 months) on the physical capacities and QoL in older adults with PD.

    The present study was aimed at people with PD who lived in the Monastir region, were enrolled in the adapted physical program, were aged between 60 and 80 years, and had no severe cognitive decline that limited their ability to make an informed decision. At first, fifty individuals participated; of these, 40 enrolled 12 to 16 months before the study was completed. A total of eight people were either inactive or had left the program before reassessment. Three individuals were excluded because of a different diagnosis of idiopathic PD (Lewy body dementia) (n = 2) and essential tremors (n = 1), while one participant who was involved as a co-researcher in this study was also excluded due to his status on the team. Finally, one participant could not be re-evaluated in time because of the sanitary confinement caused by COVID-19, and another refused to sign the consent paperwork.

    Of the 28 potential participants, 26 provided their consent to participate in the study. The subjects were informed about the experimental protocol and signed a written consent form according to the standards and guidelines of the Protection Committee of the University of Monastir (Tunisia).

    All participants gave their informed consent for inclusion before they participated in the study. The research was conducted according to the guidelines of the Declaration of Helsinki and approved by the ethical advisory committee of the Research Unit (UR17JS01) Sports Performance, Health and Society, Higher Institute of Sport and Physical Education of Ksar Saîd, University of Manouba, Tunis, 2010, Tunisia. Additionally, all procedures that were performed with human participants were in accordance with the ethical standards. The study protocol was accepted by the Ethical Commission of Manouba University in April 2023 (Ref: HE24FEB2006-B223822).

    The selected physical program is composed of 3 sessions per week. Hoehn & Yahr (H&Y) 1–2 participants had the option of inviting a close caregiver (called cornerman) to either assist them or participate alongside them, while H&Y 3–4 participants were almost always accompanied for safety reasons. Furthermore, the training structure used an appropriate approach to the participants according to their health condition: the exercises were adjusted according to physical limitations (e.g., total hip prosthesis) or signs of severity of the disease (e.g., risk of loss of balance and fall), which included wearing a belt on the waist, praticing the exercise, and sitting in a wheelchair. At the beginning of each course, the participants put elastic bandages around their hands and wrists to support their joints.

    Each session was composed as follows: 10 minutes warm-up on the tredmill with a 3 to 5 klm/h speed, which indicated a normal to moderate intensity (50–65 bpm/min); twenty minutes of adapted boxing exercises on a bag with right and left hands in two situations—static and dynamic—separated by interval training; twenty minutes of balance and gait training using a Bosu Ball, a medicine ball (1 kg), and elastic bands (10 and 15 kg); and a return to calm (5–10 minutes) with a static stretching of the muscles at various joints (elbows, knees, shoulders, neck, wrists, ankles, and hips) and various breathing techniques. We encouraged the participants to adopt a healthy and active lifestyle, thereby allowing them to attend classes once, twice, or three times a week without any restrictions on their outdoor activities. At each meeting, they need to sign a presence register to assess their attendance.

    Eligible individuals for this study included people with PD who participated in the adapted physical program for at least one year, had a reassessment, and consented to their data being extracted from their medical file. However, individuals with secondary or atypical parkinsonism were excluded (Lewy body dementia and essential tremors). Finally, those who were unable to complete the reassessment due to health problems were also excluded.

    Postural control and balance were evaluated with the Fullerton Advanced Balance Scale (FAB) test to assess the risk of falling [18]. Ten tasks needed to be completed and were rated by the appraiser on a 5-point scale (0 to 4) with specific achievement criteria according to the task. A maximum score of 40 points indicated a high performance, and this test is one of the most standardized test for people with PD, with an excellent interjudge and test-retest fidelity (CCI [3],[1] ≥ 0.95) [19],[20].

    Mobility was evaluated with the Timed Up and Go (TUG) test, which is norally validated in people with PD [21]. The participant started the test on a standard 48.5 cm high chair with armrests, in which the participant's back touched the back of the chair and their feet touched the floor. At the evaluator's signal, the participant rose from the chair, which started from a starting position with their hands on the armrests, bypassed a cone placed in front of the seat at a distance of three meters, and returned to reassure themself on the chair as quickly as possible in a safe manner. The TUG test-retest is a beneficial tool for people PD (r = 0.73–0.99; CCI [3.1] = 0.87–0.99) [21]. The Minimal Detectable Change (MDC) for this population varied widely between 2 and 11 seconds. A previous study combined the TUG with a dynamic walking index and established a 3.5-second MDC; however, it did not include participants with an initial score greater than 20 seconds [22].

    The endurance and strength of the lower limbs were measured using the 30-second chair lift test (TLC30), which is a valid test for people with PD [23]. The participant started the test sitting on a chair at a standard height of 48.5 cm without arm support, with their arms crossed on the chest and their hands on the shoulders. Then, the participant rose and elevated the chair completely for 30 seconds, and tried to perform as many repetitions as possible. If a replay was already started in the 30th second, it was compiled. The 30-second chair lift is a validated test to detect changes over time in people with PD and has moderate to excellent test-retest and interjudge reliability (CCI [2.2] = 0.94) [24],[25].

    Finally, the strength of the upper limbs was evaluated with a tension strength test (Digital Dynamometer EH101-17; Camry, Seattle, WA, USA) during the reassessment so that the data could be used in further research and the sample could be compared to those in the literature. The participant took the device, adjusted it to the size of their hand so that it had a 90-degree angle to the proximal phalanges, and fixed it upright, with foot-wide shoulders and their arms along the body. Two hand trials were conducted, and the best score for each hand was compiled.

    QoL was evaluated with the 39-question Parkinson's Disease Questionnaire (PDQ-39). This is a valid tool specially designed to measure the effects of PD on the QoL [26]. This is a questionnaire comprised of 39 questions divided into eight categories: mobility, daily life activity, emotions and well-being, stigma, social support, cognition, communication, and physical pain. The respondent chose a response based on the last 30 days, which qualified their perception for each statement and results in a score between 0 and 4. A total score is used, and a maximum of 100 indicated the lowest possible QoL.

    This classification is based on the H&Y scale, which makes it possible to classify participants according to their motor symptoms. For example, a score of 1 shows only a unilateral injury, usually with or without a functional impairment, whereas a rating of 4 is a severely disabling injection, though the individual is still able to walk or stand without help. The classification of the participants in the H&Y 1–2 and H&Y 3–4 groups was performed by a clinical nurse and associate professor at the University of Monastir. Furthermore, the age and time factors of the participants are particularly important variables for the initial diagnosis and can generally reflect a more advanced degree of severity [27].

    Program attendance was assessed through the participant's presence during the physical training sessions and was recorded in computer databases. The attendance percentage reflected the number of courses a person attended based on the total number of classes offered individually (taking public holidays into account).

    The sample size of our population was small, and the normality of the data was checked with the Shapiro-Wilk test and the visual histogram analysis [28]. Statistical analyses were unable to demonstrate a normal distribution for all data, and the measurements are presented in medians and interquartile extents. In addition, non-parametric tests were used to analyze the data. Wilcoxon-signed rows were used to meet the principal objective and to assess the effect of the program on the variables under study (physical capacity and quality of life) for all participants, as well as in each group separately (H&Y 1–2 and H&Y 3–4), in order to consider the severity of the PD. To assess whether the severity level influenced the changes induced by the physical program, a comparison of delta changes (revaluation value and initial evaluation value) of the groups was performed with the Mann-Whitney U test. The Chi-Square test was used to compare the frequencies of qualitative data between groups. The significance threshold was set to p ≤ 0.05, and the analysis was performed using the SPSS software, version 25.0 (IBM).

    The study sample included 26 participants with a diagnosis of PD, who lived in Monastir region, and mostly suffered from chronic comorbidities. No serious events occurred during the training; additionally, 17 of the 26 participants (65.4%) had joint pain and movement limitations. The program attendance rate was 58% for all 26 participants. The engagement was slightly higher in H&Y groups 3–4, with 69% versus 57% for H&Y groups 1–2. Table 1 presents the characteristics of the participants, their attendance at the physical program, their resilience to reassessment, and their comorbidities. There is a significant difference between the two groups in terms of age and comorbidities.

    Table 1.  Characteristics of participants.
    Groups Total Population
    (N=26)
    H&Y 1-2
    (N=20)
    H&Y 3-4
    (N=6)
    Group Comparison
    (p)
    Age (years) 69 (47-82) 67 (47-82) 76 (64-77) .011
    65 years and under (n (%)) 8 (31) 7 (35) 1 (17) .393
    65 ans and over (n (%)) 18 (69) 13 (65) 5 (83) .392
    Time since diagnosis (Year) 4,9 (1,3 – 16,7) 4,8 (1,3 – 16,7) 6 (3 – 16,1) .301
    Days between evaluations 431 (406 – 467) 427 (385 – 478) 451 (423 – 501) .144
    Men (n (%)) 16 (62) 13 (65) 3 (50) .516
    Levodopa (mg/day) 500 (100 – 950) 475 (100 – 900) 725 (450 – 950) .058
    Number of meetings attended 61 (47 – 76) 60 (37 – 75) 69 (57 – 86) .201
    Assiduity (%) 58 (19 – 85) 57 (19 – 85) 69 (44 – 78) .377
    Strength of strain (kg) 63.1 (48.2 – 75.2) 63.8 (49.8 – 63,8) 48.7 (45.8 – 70.6) .224
    Hypotension (n (%)) 7 (27) 5 (25) 2 (33) .686
    Type 2 diabete (n (%)) 3 (12) 0 (0) 3 (50) .001
    Thyroid gland problem (n (%)) 6 (23) 4 (20) 2 (33) .497
    Cardiovascular history (n (%)) 4 (15) 2 (10) 2 (33) .165
    Cancer (n (%)) 3 (12) 1 (5) 2 (33) .567
    Physical limitations (n (%)) 17 (65) 14 (70) 3 (50) .366

     | Show Table
    DownLoad: CSV

    The time required to complete the TUG for all participants decreased from 7.3 to 6.0 seconds (p = 0.0001). In each group, a significant reduction was observed (H&Y 1–2: 6.6 to 5.1 seconds, p = 0.0001; H&Y 3–4: 10.1 to 7.3 seconds, p = 0.028). For all groups, 24 participants (92.3%) improved their scores, while 2 participants (7.7%) took more time to complete the task, with 0.30 and 0.78 seconds within a possible margin of error, respectively (Minimal Detectable Change between 2 and 11 seconds).

    The maximum number of performed repititions in TLC30 for all participants improved significantly from 12.0 to 14.5 (p = 0.001). In the H&Y 1–2 group, the number of repetitions increased from 12.0 to 15.0 (p = 0.003) and from 10.5 to 13.0 in the H&Y 3–4 group, but was not significant (p = 0,10). The percentage of improvement was 80.8%.

    The FAB results remained unchanged in all groups (p = 0.80), as well as in each group separately (H&Y 1–2: p = 0,59; H&Y 3–4: p = 0.92). The physical performance results are summarized in Table 2.

    Table 2.  Physical capacity before and after the physical intervention.
    Group Total Population
    (N = 26)
    H&Y 1-2
    (n = 20)
    H&Y 3-4
    (n = 6)
    Group Comparison
    (p)
    TUG (sec)
     Before 7.3 [6.2– 8.6] 6.6 [5.8 – 8.0] 10.1 [8.0 – 15.9] .006
     After 6.0 [4.9 – 6.8] * 5.1 [4.7 – 6.4] * 7.3 [8.0 – 15.9] * .003
     ∆ - 1.8 [-2.3 – -0.7] -1.6 [-2.1 – -0.7] -2.4 [-5.9 – -1.8] .024
    TLC30 (rep)
     Before 12.0 [10.8 – 14.3] 12.0 [11.3 – 15.0] 10.5 [8.8 – 11.5] .023
     After 14.5 [12.8 – 17.3] * 15.0 [14.0 – 17.8] * 13.0 [9.8 – 15.0] .098
     ∆ 3.0 [0.0 – 4.0] 3.0 [0.3 – 4.0] 2.5 [-0.3 – 4.8] .806
    FAB (score)
     Before 34.5 [29.0 – 38.0] 36.5 [31.5 – 38.0] 24.0 [18.5 – 31.0] .005
     After 33.5 [29.5 – 38.0] 36.5 [30.5 – 38.0] 26.5 [16.8 – 34.5] .026
     ∆ 0.0 [-3.3 – 3.0] 0 [-2.8 – 1.8] +1 [-6.8 – 7.3] .783

    * = p ≤ 0,05: Significant difference from the initial values (Wilcoxon signed range test). Comparison between groups performed with Mann-Whitney U tests. Values are presented in median [interquartile length].

     | Show Table
    DownLoad: CSV

    The overall PDQ-39 score significantly increased for both groups, thus suggesting a decrease in the QoL. In Table 3, a significant alteration is noted by an increase in the total score (p = 0.05), with changes in the dimensions of stigma (p = 0.006) and communication (P = 0.016). The other sub-scales showed no difference. Furthermore, only the participants in H&Y group 1–2 showed a significant increase in the total score (p = 0.02), as well as changes in the same dimensions of stigma (p = 0.009) and communication (p = 0.0013), in addition to the field of cognition (p = 2.09). Since there were three incomplete questionnaires during the initial evaluation, it is important to clarify that the comparison results before and after are based on the analysis of the results of 23/26 participants.

    Table 3.  Evolution of quality of life as a result of intervention.
    Variables Total Population
    (N = 26)
    H&Y 1-2
    (N = 20)
    H&Y 3-4
    (N = 6)
    Group Comparison
    (p)
    TUG Before 12.3 [8.9 – 16.2] 10.2 [8.7 – 14.4] 26.1 [17.3 – 36.2] .006
    After 16.1 [12.1 – 24.4] * 16.1 [11.8 – 23.3] * 17.3 [11.9 – 32.6] .503
    Mobility Before 5.0 [0.0 – 20.0] 2.5 [0.0 – 10.0] 46.3 [10.6 – 66.9] .108
    After 10.0 [0.9 – 17.5] 7.5 [0.0 – 12.5] 18.8 [15.0 – 31.3] .009
    AVQ Before 20.8 [12.5 – 25.0] 20.8 [8.3 – 20.8] 37.5 [21.9 – 43.7] .043
    After 12.5 [4.2 – 21.9] 12.5 [4.2 – 20.8] 12.5 [3.1 – 43.8] .806
    Emotional well-being Before 16.7 [12.5 – 25.0] 16.7 [8.3 – 20.8] 20.8 [13.5 – 37.5] .324
    After 16.7 [8.3 – 29.2] 16.7 [8.3 – 25.5] 29.2 [8.3 – 38.5] .199
    Stigma Before 0.0 [0.0 – 12.5] 0.0 [0.0 – 6.25] 6.3 [0.0 – 21.9] .397
    After 12.5 [0.0 – 18.8] * 12.5 [0.0 – 18.75] * 3.1 [0.0 – 23.4] .592
    Social support Before 0.0 [0.0 – 0.0] 0.0 [0.0 – 0.0] 0.0 [0.0 – 12.5] .246
    After 0.0 [0.0 – 8.3] 0.0 [0.0 – 3.1] 8.3 [0.0 – 27.1] .037
    Cognition Before 12.5 [6.3 – 31.3] 12.5 [6.3 – 18.8] 34.4 [31.3 – 46.9] .003
    After 18.8 [6.3 – 39.8] 18.8 [6.3 – 51.6] * 15.6 [6.3 – 28.1] .480
    Communication Before 0.0 [0.0 – 16.7] 0.0 [0.0 – 8.3] 16.7 [0.0 – 39.6] .215
    After 8.3 [8.3 – 33.3] * 8.3 [8.3 – 31.2] * 16.7 [6.2 – 41.7] .639
    Physical discomfort Before 25.0 [16.7 – 41.7] 25.0 [16.7 – 41.7] 37.5 [25.0 – 65.6] .131
    After 37.5 [16.7 – 50.0] 33.3 [16.7 – 50.0] 41.7 [20.8 – 50.0] .902

    = p ≤ 0,05: Significant difference from the initial values (Wilcoxon signed range test). Comparison between groups made with Mann-Whitney U tests. Values are presented in median [interquartile length].

     | Show Table
    DownLoad: CSV

    With regard to the perception of the symptoms of the participants, Figure 1 presents detailed results and differences between the groups. In total, 34.1% perceived a deterioration, 52.9% peceived no change, and 13.0% perceived an improvement.

    Figure 1.  Perception of sympthoms changes.

    The principal objective of this study was to assess the long-term effects of a physical training program on the functional capacity and QoL of people with PD. The results of this study should be interpreted with caution, as they highlight the benefits of long-term participation in a physical training program on motor function and life quality in older participants with mild and moderate level of PD.

    Older peoples with PD invariably experience functional declines in a number of motor domains including posture, balance, gait, and transfers. After 12 to 16 months of participation in the program, the effects appear to be primarily beneficial for mobility, including a reduction in the time required to complete the TUG and an increase in the endurance of the lower limbs (increased number of rehearsals in the TLC30). While 24/26 participants improved their TUG scores, only 11/26 (42.3%) exceeded the minimum 2-second MDC. Regarding the endurance of the lower limbs, 15/26 (57.7%) exceeded the Minimal Detectable Change (TLC30: 3 rehearsals). However, this improvement did not result in changes in their static and dynamic balances (FAB). In the context of the Parkinson disease, this absence of change after 12 to 16 months could be regarded as an important maintenance: 46.2% of the participants improved their score within the values and 7/26 (26.9%) exceeded the MDC (2.25 points).

    These findings are consistent with the literature that assessed the effects of a short-term training program and therefore support the role of a physical program on the motor capacity, which is an important component of functional capacity despite the evolution of PD. However, the absence of a significant balance benefit is surprising, as it differs from the study of Combs et al. [17], which displayed an improvement in balance, as measured with the Berg Balance Scale after a 12-week intervention (24 to 36 sessions). In comparison, our 12- to 16-month study resulted in a median participation of 61 sessions. Apart from the progression of the disease, the difference in the balance results could be explained, in part, by the volume of training. Indeed, if we compare the average of 30 sessions for 12 weeks (rate of 2.5/week) versus 61 sessions for 56 weeks (ratio of 1.09/week), we can understand that the participants in our study did not complete the same training load, and therefore did not meet the recommendations of Gallo et al. 2011 [29]. This difference is probably explained by multiple reasons, because the minimum number of sessions was already one of the exclusion criteria for the study.

    In the study of Mehrholz et al. [30], the results showed that treadmill training improved balance, gait, and lead to important improvments of the walking parameters. Herman's research review concluded that treadmill training should play an essential role in improving gait and mobility in the care of individuals with PD [31]. However, resistance training (RT) is a relatively new technique for older people with neurodegenerative diseases. Saltychev et al. [32] emphasized the importance of resistance and strength training in people with PD. Furthermore, few studies have shown a positive effect of RT using medicine ball and elastic band exercises on the muscle strength and mobility of patients with PD [33]. A multicomponent physical program based on aerobic and strength exercise interventions was shown to be an effective method to delay the progression of PD. Thus, to make definite clinical recommendations on the possible use of resistance training for patients with PD, further studies should concentrate on larger sample sizes with sufficient follow-up periods.

    Among the various AP interventions offered to people with PD, the contactless adapted boxing emerged as a non-traditional sensor motor training for functional capacity. This type of training is of interest to those affected, as it could help to improve several components of physical capacity affected by PD [34],[35]. Only a few studies have assesed the effects of adapted boxing treaining and resistance exercices on the motor function of aged people with PD [36]. Physical exercise represents a complementary treatment option, yet previous studies have failed to demonstrate its uniform benefit on mobility [37],[38].

    The present reseach has a much greater ecological validity since the intervention was offered in the community environment without a control for assiduity. The objective was to improve the motor function, and the presented results here reflect the reality of a community program, which leaves a free choice for participation to improve their well-being. However, if a certain amount of training is needed to balance the benefits and reduce the significant risk of falling in this population [39], it would be important to advise the participants and their cornermen who enroll in this type of program. However, further research is needed to determine whether an optimal volume of suitable boxing training exists for this population. Scientific research has mainly focused on identifying PA barriers among patients with PD; however, there is a paucity of research on other relevant factors related to the PA behavior. For instance, there is a lack of knowledge regarding the pre-diagnosis PA behavior of people with PD, which may be useful in understanding their physical activity engagement [40]. Similarly, additional studies are necessary to investigate the relationship betwen PA levels and factors such as the QoL or the impairment level [41].

    Concerning the QoL, a slight decrease (PDQ-39) was observed at the time of reassessment. This change seems to be mainly linked to the decline in stigma, communication, and cognition. In the absence of a monitoring group, it remains difficult to know the extent of this decline. It is possible that the reason of this decrease could have been much larger. Evidence from previous studies regarding the influence of exercise on QoL considerably varies. Moreover, a study that followed 728 people with Parkinson disease for 6 months displayed a decline in all dimensions of the QoL [42]. When we analyzed the changes in the present study before and after the physical intervention, it seems that the physical program did not slow down the decline in the QoL that occurs with PD. Indeed, the decline observed for the cognitive dimension was greater for the H&Y group 1–2, which can be explained by several factors. This may be due to the natural progression of the disease; however, other possibilities exist that can play a role in either increasing or decreasing the QoL, such as a different diagnosis of PD among the participants in the H&Y group 1–2 and other factors such as the environment (everyday tasks).

    Furthermore, it is also necessary to mention some factors releated to the decline of certain activities under the selected physical program. In fact, the warm-up often contained an activity that required the participants to speak in front of the group; two aspects, namely the ability to speak and the pronounciation, may decrease with the disease [43]. Although the adapted physical program was aimed at breaking isolation and promoting socialization, the decline observed in the various dimensions could be explained by the discomfort of some participants in exposing their symptoms to the rest of the group. Moreover, studies report that people with PD can sometimes experience a sense of shame about their language difficulties and the visibility of their condition [44]; however, it remains desirable to offer opportunities to verbally expess themselves and to promote communication with peers in order to break the isolation in this population, since patients with Parkinson's or Alzheimer diseases suffer from loneliness and isolation, which can easily affect their QoL and cognitive function [45],[46]. Future studies should assess the impact of different approaches used in a complex program on the various dimensions in adults with PD. The QoL results highlight certain limitations of group training, such as the ability to take the principle of training individualization into account. This is why some authors propose multidisciplinary interventions to better manage the symptoms of people with PD. For example, massage therapy could improve physical discomfort symptoms [47], whereas psychotherapy could help better manage anxiety and depression symptoms [48]. On the other hand, in a context of limited human and financial resources, the physical program proposed in the present study appears to meet several components necessary for the adequate care of persons with disabilities.

    The low number of participants in the H&Y 3–4 group greatly limits the interpretation and comparison of groups according to the severity of PD. The exploratory findings indicated that both groups produced similar results, although those with a higher degree of severity (H&Y 3–4) achieved slightly greater improvements in mobility (TUG). The execution of complex tasks under supervision during all the intervention may have contributed to an increase in the sense of competence and confidence of the participants, which was reflected in a higher speed of execution of the TUG. However, the participants in the H&Y group 3–4 showed more severe symptoms; therefore, the possibility that they may have presented kinesiophobia at the beginning of the program, which could have reduced performance during the initial evaluation, should not be overlooked.

    The data from this study did not confirm all the expected benefits for this type of activity. Although a community-specific physical program appears to have a stabilizing (maintaining) effect on physical capacity, in future research, it would be necessary to add a control group to facilitate the comparison and examination of the results. Furthermore, we believed that persons with mild to moderate conditions would react better than those with a higher severity score due to their cognitive reserve; it is clear that further research is needed in this area. It might be interesting to evaluate the long-term effect of a physical program with a higher training supply that would meet the recommendation of 3 to 5 times a week.

    Furthermore, it is crucial to determine who prescribes physical exercises to older adults with PD and what solutions are available to slow down the progression of this disease. Neurologists are expected to provide the best physical programs and recommendations for patients with PD after identifying their specific needs. Nonetheless, physical educators and practitioners can also deliver diagnoses, initial treatments, and the regular and timely management of PD, most particularly in the clinical exercise field, where physical activity guidelines for populations with PD are still not very clear and need further research [49].

    Epidemiological data has indicated that exercise may reduce the risk of developing PD. There is currently a solid body of clinical evidence demonstrating that PA is a helpful, cost-effective, and low-risk intervention that improves the general health and has the potential to alleviate both motor and cognitive symptoms in patients with PD [50]. A physical program appeared to be a good approach to improve and maintain the physical parameters and mental functions. While this study only displayed slightly significant benefits, further research on PA is required to determine the best forms of therapy in people with PD and across the spectrum of its symptom burden. This would be further supported by studies that indicate the positive association of PA and neural functions with the strong potential of this therapeutic modality to be better translated to and applied in the management of PD.



    Conflict of interest



    The authors declare no conflict of interest.

    Author contributions



    GO devised the main research topic and planned the literature search. GO conceived the conceptual ideas and proof outline. GO, CC, AR and LM drafted the first version of the manuscript; GO, VC, and EM drafted the second version of the manuscript; GO, VC, EM, DM, CS contributed to the data interpretation; GO, VC, EM, CC, DM, AR, CS and AG revised the manuscript critically. All authors gave the final approval for the version to be published.

    [1] World Obesity Day [Internet]World Obesity Federation. [cited 2022 Jul 13]. Available from: https://www.worldobesity.org/what-we-do/world-obesity-day
    [2] Iasevoli M, Giantin V, Voci A, et al. (2012) Discussing end-of-life care issues with terminally ill patients and their relatives: comparisons among physicians, nurses and psychologists. Aging Clin Exp Res 24: 35-42.
    [3] Salari N, Hosseinian-Far A, Jalali R, et al. (2020) Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Globalization Health 16: 57. https://doi.org/10.1186/s12992-020-00589-w
    [4] Maharaj PE, Barclay N, Descartes C, et al. (2019) Intimate Partner Violence and Sleep: An Overview of Sleep Disturbances and Interventions. Handbook of Interpersonal Violence and Abuse Across the Lifespan: A project of the National Partnership to End Interpersonal Violence Across the Lifespan (NPEIV) [Internet] . Cham: Springer International Publishing p. 1-25. Available from: https://doi.org/10.1007/978-3-319-62122-7_132-1. [cited 2022 May 12]
    [5] Mattioli AV, Pinti M, Farinetti A, et al. (2020) Obesity risk during collective quarantine for the COVID-19 epidemic. Obes Med 20: 100263. https://doi.org/10.1016/j.obmed.2020.100263
    [6] Weingarten HP, Elston D (1990) The phenomenology of food cravings. Appetite 15: 231-246. https://doi.org/10.1016/0195-6663(90)90023-2
    [7] Pelchat ML, Johnson A, Chan R, et al. (2004) Images of desire: food-craving activation during fMRI. Neuroimage 23: 1486-1493. https://doi.org/10.1016/j.neuroimage.2004.08.023
    [8] Bénard M, Camilleri GM, Etilé F, et al. (2017) Association between Impulsivity and Weight Status in a General Population. Nutrients 9: E217. https://doi.org/10.3390/nu9030217
    [9] Favieri F, Forte G, Casagrande M (2019) The Executive Functions in Overweight and Obesity: A Systematic Review of Neuropsychological Cross-Sectional and Longitudinal Studies. Front Psychol . https://doi.org/10.3389/fpsyg.2019.02126
    [10] Basdevant A, Craplet C, Guy-Grand B (1993) Snacking patterns in obese French women. Appetite 21: 17-23. https://doi.org/10.1006/appe.1993.1033
    [11] Narayanaswami V, Dwoskin LP (2017) Obesity: Current and potential pharmacotherapeutics and targets. Pharmacol Ther 170: 116-147. https://doi.org/10.1016/j.pharmthera.2016.10.015
    [12] Uher R, Murphy T, Brammer MJ, et al. (2004) Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am J Psychiatry 161: 1238-1246. https://doi.org/10.1176/appi.ajp.161.7.1238
    [13] Fabricatore AN, Wadden TA (2004) Psychological aspects of obesity. Clin Dermatol 22: 332-337. https://doi.org/10.1016/j.clindermatol.2004.01.006
    [14] Kim S, Lee D (2011) Prefrontal Cortex and Impulsive Decision Making. Biol Psychiatry 69: 1140-1146. https://doi.org/10.1016/j.biopsych.2010.07.005
    [15] Szabo-Reed AN, Martin LE, Hu J, et al. (2020) Modeling interactions between brain function, diet adherence behaviors, and weight loss success. Obes Sci Pract 6: 282-292. https://doi.org/10.1002/osp4.403
    [16] Orrù G, Baroni M, Cesari V, et al. (2019) The effect of single and repeated tDCS sessions on motor symptoms in Parkinson's disease: a systematic review. Arch Ital Biol 157: 89-101. https://doi.org/10.12871/00039829201925
    [17] Orrù G, Cesari V, Baroni M, et al. (2020) Letter to the Editor: the application of transcranial direct current stimulation on phantom phenomena. Mediterr J Clin Psyc 8. Available from: https://cab.unime.it/journals/index.php/MJCP/article/view/2382
    [18] Orrù G, Cesari V, Conversano C, et al. (2021) The clinical application of transcranial direct current stimulation in patients with cerebellar ataxia: a systematic review. Int J Neurosci 131: 681-688. https://doi.org/10.1080/00207454.2020.1750399
    [19] Orrù G, Conversano C, Hitchcott PK, et al. (2020) Motor stroke recovery after tDCS: a systematic review. Rev Neurosci 31: 201-218. https://doi.org/10.1515/revneuro-2019-0047
    [20] Chen J, Qin J, He Q, et al. (2020) A Meta-Analysis of Transcranial Direct Current Stimulation on Substance and Food Craving: What Effect Do Modulators Have?. Front Psychiatry 11: 598. https://doi.org/10.3389/fpsyt.2020.00598
    [21] Nitsche MA, Paulus W (2000) Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 527: 633-639. https://doi.org/10.1111/j.1469-7793.2000.t01-1-00633.x
    [22] Nitsche MA, Fricke K, Henschke U, et al. (2003) Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol 553: 293-301. https://doi.org/10.1113/jphysiol.2003.049916
    [23] Angius L, Santarnecchi E, Pascual-Leone A, et al. (2019) Transcranial Direct Current Stimulation over the Left Dorsolateral Prefrontal Cortex Improves Inhibitory Control and Endurance Performance in Healthy Individuals. Neuroscience 419: 34-45. https://doi.org/10.1016/j.neuroscience.2019.08.052
    [24] Ota K, Shinya M, Kudo K (2019) Transcranial Direct Current Stimulation Over Dorsolateral Prefrontal Cortex Modulates Risk-Attitude in Motor Decision-Making. Front Hum Neurosci 13: 297. https://doi.org/10.3389/fnhum.2019.00297
    [25] Friehs MA, Frings C, Hartwigsen G (2021) Effects of single-session transcranial direct current stimulation on reactive response inhibition. Neurosci Biobehav R 128: 749-65. https://doi.org/10.1016/j.neubiorev.2021.07.013
    [26] Lowe CJ, Vincent C, Hall PA (2017) Effects of Noninvasive Brain Stimulation on Food Cravings and Consumption: A Meta-Analytic Review. Psychosom Med 79: 2-13. https://doi.org/10.1097/PSY.0000000000000368
    [27] Mostafavi SA, Khaleghi A, Mohammadi MR, et al. (2020) Is transcranial direct current stimulation an effective modality in reducing food craving? A systematic review and meta-analysis. Nutr Neurosci 23: 55-67. https://doi.org/10.1080/1028415X.2018.1470371
    [28] Orru G, Miniati M, Conversano C, et al. (2021) A machine learning analysis of psychopathological features of Eating Disorders: a retrospective study. Mediterr J Clin Psyc 9. Available from: https://cab.unime.it/journals/index.php/MJCP/article/view/2670
    [29] Meule A, Küppers C, Harms L, et al. (2018) Food cue-induced craving in individuals with bulimia nervosa and binge-eating disorder. PLOS ONE 13: e0204151. https://doi.org/10.1371/journal.pone.0204151
    [30] Moher D, Liberati A, Tetzlaff J, et al. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535. https://doi.org/10.1136/bmj.b2535
    [31] da Costa Santos CM, de Mattos Pimenta CA, Nobre MRC (2007) The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem 15: 508-511. https://doi.org/10.1590/S0104-11692007000300023
    [32] Mendeley - Reference Management Software [Internet]. [cited 2022 Jul 13]. Available from: https://www.mendeley.com/?interaction_required=true
    [33] Jadad AR, Moore RA, Carroll D, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17: 1-12. https://doi.org/10.1016/0197-2456(95)00134-4
    [34] Higgins JPT, Altman DG, Gøtzsche PC, et al. (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343: d5928. https://doi.org/10.1136/bmj.d5928
    [35] Grundeis F, Brand C, Kumar S, et al. (2017) Non-invasive Prefrontal/Frontal Brain Stimulation Is Not Effective in Modulating Food Reappraisal Abilities or Calorie Consumption in Obese Females. Front Neurosci 11: 334. https://doi.org/10.3389/fnins.2017.00334
    [36] Ray MK, Sylvester MD, Helton A, et al. (2019) The effect of expectation on transcranial direct current stimulation (tDCS) to suppress food craving and eating in individuals with overweight and obesity. Appetite 136: 1-7. https://doi.org/10.1016/j.appet.2018.12.044
    [37] Marron EM, Viejo-Sobera R, Cuatrecasas G, et al. (2019) Prefronto-cerebellar neuromodulation affects appetite in obesity. Int J Obes (Lond) 43: 2119-2124. https://doi.org/10.1038/s41366-018-0278-8
    [38] Gluck ME, Alonso-Alonso M, Piaggi P, et al. (2015) Neuromodulation targeted to the prefrontal cortex induces changes in energy intake and weight loss in obesity. Obesity 23: 2149-2156. https://doi.org/10.1002/oby.21313
    [39] Heinitz S, Reinhardt M, Piaggi P, et al. (2017) Neuromodulation directed at the prefrontal cortex of subjects with obesity reduces snack food intake and hunger in a randomized trial. Am J Clin Nutr 106: 1347-1357. https://doi.org/10.3945/ajcn.117.158089
    [40] Lenhard W, Lenhard A Computation of Effect Sizes (2017).
    [41] Wilson SJ, Sayette MA, Fiez JA (2004) Prefrontal responses to drug cues: a neurocognitive analysis. Nat Neurosci 7: 211-214. https://doi.org/10.1038/nn1200
    [42] Alonso-Alonso M, Pascual-Leone A (2007) The right brain hypothesis for obesity. JAMA 297: 1819-1822. https://doi.org/10.1001/jama.297.16.1819
    [43] Legget KT, Wylie KP, Cornier MA, et al. (2020) Altered between-network connectivity in individuals prone to obesity. Physiol Behav 113242. https://doi.org/10.1016/j.physbeh.2020.113242
    [44] Son NT Le D, Pannacciulli N, Chen K, et al. (2007) Less activation in the left dorsolateral prefrontal cortex in the reanalysis of the response to a meal in obese than in lean women and its association with successful weight loss. Am J Clin Nutr 86: 573-579. https://doi.org/10.1093/ajcn/86.3.573
    [45] Wager TD, Atlas LY (2015) The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci 16: 403-418. https://doi.org/10.1038/nrn3976
    [46] Benedetti F, Carlino E, Pollo A (2011) How Placebos Change the Patient's Brain. Neuropsychopharmacology 36: 339-354. https://doi.org/10.1038/npp.2010.81
    [47] Heekeren HR, Marrett S, Bandettini PA, et al. (2004) A general mechanism for perceptual decision-making in the human brain. Nature 431: 859-862. https://doi.org/10.1038/nature02966
    [48] Rolls ET, Critchley HD, Browning A, et al. (1998) The Neurophysiology of Taste and Olfaction in Primates, and Umami Flavora. Ann NY Acad Sci 855: 426-437. https://doi.org/10.1111/j.1749-6632.1998.tb10602.x
    [49] Kumar S, Grundeis F, Brand C, et al. (2016) Differences in Insula and Pre-/Frontal Responses during Reappraisal of Food in Lean and Obese Humans. Front Hum Neurosci 10: 233. https://doi.org/10.3389/fnhum.2016.00233
    [50] Berman BD, Horovitz SG, Hallett M (2013) Modulation of functionally localized right insular cortex activity using real-time fMRI-based neurofeedback. Front Hum Neurosci . https://doi.org/10.3389/fnhum.2013.00638
    [51] Noori HR, Cosa Linan A, Spanagel R (2016) Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: A comprehensive meta-analysis. Eur Neuropsychopharmacol 26: 1419-1430. https://doi.org/10.1016/j.euroneuro.2016.06.013
    [52] Bryant M, Truesdale KP, Dye L (2006) Modest changes in dietary intake across the menstrual cycle: implications for food intake research. Br J Nutr 96: 888-894. https://doi.org/10.1017/BJN20061931
    [53] Accornero N, Capozza M, Pieroni L, et al. (2014) EEG mean frequency changes in healthy subjects during prefrontal transcranial direct current stimulation. J Neurophysiol 112: 1367-1375. https://doi.org/10.1152/jn.00088.2014
    [54] Noetscher GM, Yanamadala J, Makarov SN, et al. (2014) Comparison of cephalic and extracephalic montages for transcranial direct current stimulation--a numerical study. IEEE Trans Biomed Eng 61: 2488-2498. https://doi.org/10.1109/TBME.2014.2322774
    [55] Misonou H, Mohapatra DP, Park EW, et al. (2004) Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci 7: 711-718. https://doi.org/10.1038/nn1260
    [56] Prehn K, Flöel A (2015) Potentials and limits to enhance cognitive functions in healthy and pathological aging by tDCS. Front Cell Neurosci . https://doi.org/10.3389/fncel.2015.00355
    [57] Lefaucheur JP, Antal A, Ayache SS, et al. (2017) Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol 128: 56-92. https://doi.org/10.1016/j.clinph.2016.10.087
    [58] Davis SE, Smith GA (2019) Transcranial Direct Current Stimulation Use in Warfighting: Benefits, Risks, and Future Prospects. Front Hum Neurosci . https://doi.org/10.3389/fnhum.2019.00114
    [59] Chang CC, Kao YC, Chao CY, et al. (2020) The Effects of Bi-Anodal tDCS Over the Prefrontal Cortex Regions With Extracephalic Reference Placement on Insight Levels and Cardio-Respiratory and Autonomic Functions in Schizophrenia Patients and Exploratory Biomarker Analyses for Treatment Response. Int J Neuropsychopharmacol 24: 40-53. https://doi.org/10.1093/ijnp/pyaa063
    [60] Saxena V, Pal A (2021) Role of Transcranial Direct Current Stimulation in the Management of Alzheimer's Disease: A Meta-analysis of Effects, Adherence and Adverse Effects. Clin Psychopharmacol Neurosci 19: 589-599. https://doi.org/10.9758/cpn.2021.19.4.589
  • neurosci-09-03-020-s001.pdf
  • Reader Comments
  • © 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2904) PDF downloads(260) Cited by(4)

Figures and Tables

Figures(1)  /  Tables(2)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog